Clinical Trials
426 trialsMultimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"
University of Alabama at Birmingham
EVAX
University Hospital, Bordeaux
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
M.D. Anderson Cancer Center
3DPN
University of Leipzig
Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
Sun Yat-sen University
Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain
Institut Claudius Regaud
SPARC-1
Columbia University
ZEBRA
Istituto Oncologico Veneto IRCCS
VICKI
Institut Mutualiste Montsouris
VolUS3D
Assistance Publique - Hôpitaux de Paris
SUP-R
Institut Claudius Regaud
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
The Christie NHS Foundation Trust
KIDCaD
Charles University, Czech Republic
EXO-RENAL2
Institute of Oncology Ljubljana
EXO-RENAL1
Institute of Oncology Ljubljana
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
St. Jude Children's Research Hospital
A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma
Beth Israel Deaconess Medical Center
RREIN
University Hospital, Lille
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
City of Hope Medical Center
Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy
H. Lee Moffitt Cancer Center and Research Institute
PIONEER-OPT
Kantonsspital Baden
HEMOSTA-PN
Ankara University
Molecular-Guided Therapy for Childhood Cancer
Milton S. Hershey Medical Center
Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC
Goethe University
CT-based Radiomics for Prediction of MIT Family Translocation Kidney Cancer: a Multicenter, Retrospective Clinical Study
First Affiliated Hospital of Fujian Medical University
TACITO
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
CARMENA
Assistance Publique - Hôpitaux de Paris
Skippy 1
Leiden University Medical Center
EDHITO
Institut Cancerologie de l'Ouest
Computed Tomography Radiomics-Derived Nomogram for Predicting Early Renal Function Decline After Partial Nephrectomy in Renal Cell Carcinoma: A Multicenter Development/Validation Study
First Affiliated Hospital of Fujian Medical University
UNICAB
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
CABRAMET
Centre Leon Berard
Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC)
Stanford University
ABEMA Alone or in COMBO With MK-6482
Dana-Farber Cancer Institute
P-NeLoP
University Hospital, Bordeaux
Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma
Swiss Cancer Institute
Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer
Memorial Sloan Kettering Cancer Center
Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer
University of California, Davis
Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer
Thomas Jefferson University
Current Role of Pentafecta Outcomes in Open and Laparoscopic Partial Nephrectomy for Localized Renal Tumors
South Valley University
Trifecta
South Valley University
Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation
Thomas Jefferson University
Measuring Treatment Response in Metastatic Renal Cell Cancer Using FPIA PET/CT
Imperial College London
Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC)
University of Iowa
Clinical Study of 18F -FAPI-RGD in Renal Tumor
Sichuan Provincial People's Hospital
Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study
Fudan University
The CT-based Deep Learning Model Predicts Complications in Partial Nephrectomy
Fudan University
Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma
University of Colorado, Denver
A Comparative Study Between Open and Robotic Partial Nephrectomy in Treatment of High Complex Renal Tumors.
Assiut University